Literature DB >> 23890758

Retroperitoneal hematoma: an unexpected complication during intervention on an occluded superficial femoral artery via a retrograde popliteal artery approach.

Nuri I Akkus1, Jagan Beedupalli, Jai Varma.   

Abstract

Peripheral arterial disease involvement of the superficial femoral artery (SFA) is common. Different endovascular techniques are used successfully for revascularization of this artery. A retrograde approach to chronic total occlusion (CTO) of the SFA through the ipsilateral popliteal artery has been used occasionally if an antegrade approach is not feasible or has failed. Some of the known complications encountered during this approach are arteriovenous fistula formation at the access site, occlusion of the popliteal artery if closure devices are used, and bleeding. There are no reports of perforation or bleeding of the SFA or the external iliac artery (EIA) during a popliteal approach, probably due to lack of flow in the occluded segment of the SFA. We report a case in which a retroperitoneal hematoma occurred due to retrograde blood flow through the established true channel in the proximal SFA and subsequently to the dissection plane with a wire tip perforation in the EIA, which was treated by stopping retrograde filling with prolonged balloon inflation in the distal SFA before the CTO.
Copyright © 2012 Sociedade Portuguesa de Cardiologia. Published by Elsevier España. All rights reserved.

Entities:  

Keywords:  Acesso poplíteo; Artéria femoral superficial; Doença arterial periférica; Hematoma retroperitoneal; Peripheral vascular disease; Popliteal approach; Retroperitoneal hematoma; Superficial femoral artery

Mesh:

Year:  2013        PMID: 23890758     DOI: 10.1016/j.repc.2012.11.011

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN: 0870-2551            Impact factor:   1.374


  1 in total

1.  Image Diagnosis: Rapidly Enlarging Scrotal Hematoma: A Complication of Femoral Access?

Authors:  Raza Askari; Rami N Khouzam; Dwight A Dishmon
Journal:  Perm J       Date:  2017
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.